| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13550a2e931b7820247a58278354ee62 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2007-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7f3aaa8fe6049fa884b8c15df4bb26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ceffc71ea259d6c4b42aa877db2d22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80bdd16caa14ae7497da81f9dc480b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd9277619b7e73a6c1d1fea2d86ffac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5702b0e9268cac19528d790e40aa272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9b2e5b2de642726eccbf0cbbae3b97 |
| publicationDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-578126-A |
| titleOfInvention |
Phamaceutical compostions comprising Glucagon-like peptide-1 (GLP-1) analog |
| abstract |
A pharmaceutical composition of the GLP-1 analog [Aib8.35]hGLP-1(7-36)NH2. The composition comprises a mixture of the analog with a salt and divalent metal. The molar ratio of the GLP-1 analog to the divalent metal ranges from 5.4:1 to 1.5:1, and the molar ratio of the GLP-1 analog to the salt ranges from 0.5:1 to 10: 1. The salt can be a salt of hydrochloric acid or acetic acid, and the metal can be zinc or copper. The molar ratios can be adjusted to modulate the solubility, the pH and release effect on the in vivo release profile of the GLP-1 analog. |
| priorityDate |
2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |